Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

65.87
-1.8600-2.75%
Post-market: 66.500.6300+0.96%19:20 EDT
Volume:2.50M
Turnover:168.11M
Market Cap:8.12B
PE:17.52
High:69.94
Open:68.11
Low:65.68
Close:67.73
Loading ...
Jun 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities